MustGrow Biologics (TSE:MGRO) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MustGrow Biologics has announced a proposed private placement aiming to raise approximately $2 million through the issuance of convertible debentures and common share purchase warrants. The company plans to use the funds for inventory production, working capital, and general corporate purposes. This financial move aligns with MustGrow’s focus on expanding the commercialization of its organic biocontrol and biofertility products globally.
For further insights into TSE:MGRO stock, check out TipRanks’ Stock Analysis page.